Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

134

Full text

115

Free full text

Publication Types

Journal Article

133

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Clinical Trial

Research Support, N.I.H., Extramural

Meta-Analysis

Multicenter Study

Clinical Trial, Phase I

Comparative Study

Research Support, U.S. Gov't, Non-P.H.S.

Systematic Review

Observational Study

Practice Guideline

Validation Study

Clinical Trial, Phase II

Controlled Clinical Trial

Case Reports

Research Support, U.S. Gov't, P.H.S.

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Liver-Specific Organic Anion Transporter 1""[mesh_terms]

134 Results

Searching titles within these results

Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).

Hannah H Lee, Richard H Ho

British journal of clinical pharmacology 2018;83(6):1176-1184

Free Full Text

Abstract

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Jemma C Hopewell, Alison Offer, Richard Haynes, Louise Bowman, Jing Li, Fang Chen, Richard Bulbulia, Mark Lathrop, Colin Baigent, Martin J Landray, Rory Collins, Jane Armitage, Sarah Parish

European heart journal 2021;41(35):3336-3342

Free Full Text

Abstract

Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays.

Renee C Geck, Gabriel Boyle, Clara J Amorosi, Douglas M Fowler, Maitreya J Dunham

Annual review of pharmacology and toxicology 2022;62():531-550

Full Text

Abstract

The pharmacogenomics of statins.

Ingrid C Gelissen, Andrew J McLachlan

Pharmacological research 2015;88():99-106

Full Text

Abstract

Association between SLCO1B1 521 T＞C and 388 A＞G Polymorphisms and Statins Effectiveness: A Meta-Analysis.

Rong Dai, Jing Feng, Yang Wang, Yuan Yang, Changkai Deng, Xiaojun Tang, Yong Zhao, Hao Zhou, Fan Zhang

Journal of atherosclerosis and thrombosis 2016;22(8):796-815

Free Full Text

Abstract

Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy.

Laure Elens, Jean-Luc Balligand, Louise Deldicque, Vincent Haufroid, Emilia Hoste

Clinical biochemistry 2024;124():110707

Full Text

Abstract

Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis.

Hong Ha Nguyen, Cuc Thi Thu Nguyen, Tran Ngoc Phuong Mai, Phung Thanh Huong

Pharmacogenetics and genomics 2023;33(4):65-78

Full Text

Abstract

Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?

Jaime L Lopes, Kimberley Harris, Mary Beth Karow, Sandra E Peterson, Michelle L Kluge, Katrina E Kotzer, Guilherme S Lopes, Nicholas B Larson, Suzette J Bielinski, Steven E Scherer, Liewei Wang, Richard M Weinshilboum, John L Black, Ann M Moyer

The Journal of molecular diagnostics : JMD 2022;24(3):253-261

Free Full Text

Abstract

Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia.

Xiangyu Wu, Chen Gong, Justin Weinstock, Jun Cheng, Shengnan Hu, Scott A Venners, Yi-Hsiang Hsu, Suwen Wu, Xiangdong Zha, Shanqun Jiang, Yong Li, Faming Pan, Xiping Xu

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020;24(9_suppl):240S-247S

Free Full Text

Abstract

Associations between , and and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.

Zi Hao Zhang, Li Chao Yue Sun, Hong Yan Gu, De Chun Jiang, Zhan Miao Yi

Pharmacogenomics 2023;24(8):475-484

Full Text

Abstract

Rhabdomyolysis and acute kidney injury induced by the association of rosuvastatin and abiraterone: A case report and review of the literature.

Ismail Ould-Nana, Marine Cillis, Marco Gizzi, Valentine Gillion, Philippe Hantson, Ludovic Gérard

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2021;27(1):216-219

Full Text

Abstract

Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia.

Jonathan B Wagner, Susan Abdel-Rahman, Andrea Gaedigk, Roger Gaedigk, Geetha Raghuveer, Vincent S Staggs, Leon Van Haandel, J Steven Leeder

Clinical and translational science 2021;13(3):628-637

Free Full Text

Abstract

The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia.

Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Francesco Purrello, Lucia Frittitta, Agostino Milluzzo, Roberto Scicali, Salvatore Piro, Francesco Di Giacomo Barbagallo, Giosiana Bosco, Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, Salvatore Spampinato, Alessio Vitale, Federica Di Bella, Maria Montalbano

Frontiers in endocrinology 2024;15():1346152

Free Full Text

Abstract

Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.

Ling Li, Yun Li, Haoming Tian, Xin Sun, Qingtao Hou, Sheyu Li

Medicine 2015;94(37):e1268

Free Full Text

Abstract

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden, Q Feng, R M Cooper-DeHoff, L Gong, T E Klein, M Wadelius, M Niemi

Clinical pharmacology and therapeutics 2014;96(4):423-8

Free Full Text

Abstract

Results: 1 – 15 / 134

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Liver-Specific Organic Anion Transporter 1""[mesh_terms]

Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.

Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays.

The pharmacogenomics of statins.

Association between SLCO1B1 521 T＞C and 388 A＞G Polymorphisms and Statins Effectiveness: A Meta-Analysis.

Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy.

Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis.

Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?

Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia.

Associations between , and and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.

Rhabdomyolysis and acute kidney injury induced by the association of rosuvastatin and abiraterone: A case report and review of the literature.

Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia.

The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia.

Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Results for

""Liver-Specific Organic Anion Transporter 1""[mesh_terms]